Vimpat (UCB, Inc.)
Welcome to the PulseAid listing for the Vimpat drug offered from UCB, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | UCB, Inc. |
| NON-PROPRIETARY NAME: | lacosamide |
| SUBSTANCE NAME: | LACOSAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-05-26 |
| END MARKETING DATE: | 0000-00-00 |
Vimpat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vimpat from UCB, Inc. |
| LABELER NAME: | UCB, Inc. |
| DEA SCHEDULE: | CV
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2009-05-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0131-1810_acf39515-db07-4e03-bef4-2eca474a874d |
| PRODUCT NDC: | 0131-1810 |
| APPLICATION NUMBER: | NDA022254 |
Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers:
